Charles River Acquired Distributed Bio

Distributed Bio officially joined the Charles River Discovery team as of January 1, 2021, creating an unmatched, seamless service for your therapeutic antibody discovery and development.

Strengthen your program

Charles River and Distributed Bio partner to offer a humanized scfv antibody library used for antibody screening, antibody discovery and antibody engineering.

More Science

As you continue to work with the Distributed Bio™ experts, scientists, and contacts you know and trust, you’ll also have access to Charles River’s team of industry-leading scientists who excel at guiding large molecule development from lead discovery to IND.

Meet the expanded antibody team

 

More Solutions

This Distributed Bio™ antibody discovery and optimization platform create a unique end-to-end platform for therapeutic antibody programs. With the Distributed Bio acquisition, Charles River now offers an integrated target to clinic portfolio including:

 

Navigating the Early Stages of Drug Development

Charles River On-Demand Video Series: Planning for a Successful CAR-T IND During Early Discovery

California Life Sciences professionals discuss navigating the early stages of drug development in this roundtable with experts from Charles River SSF, Westlake Village BioPartners, Rubido Life Sciences, and Nitrome Biosciences. Watch the video

Accelerate Your Cell Therapy R&D

Charles River On-Demand Video Series: Planning for a Successful CAR-T IND During Early Discovery

Avoid common failures in late-preclinical and clinical stages of CAR oncology programs by conducting the right early discovery studies. Access the video series